Chemical Romance: Genre andMateria Medicain Late-Victorian Drug Fiction

Despite Macfie's vivid assertion, studies of Victorian medicine and literature have not paid special attention to the pharmaceutical field, perhaps because of its messy associations with trade or inferiority to more respected healing practices. After all, it is Doctor Lydgate's refusal to prescribe the expected drugs inMiddlemarchthat proves his commitment to evidence-based Parisian medicine. As I aim to demonstrate, however, pharmacy and its products have a distinct and two-edged history in late-Victorian England. Medical writers increasingly assert the scientific authority and physiological promise of pharmacology. At the same time, they begin to show interest in the romance of drugs: their origins in alchemy and the occult, harvesting in the furthest outreaches of empire, and, at home, display in the magical space of the chemist's shop. This productive tension between medicinal drugs as stuff of ancient mystery and sign of medical progress informs their depiction in the transforming drug narratives of Robert Louis Stevenson'sStrange Case of Dr. Jekyll and Mr. Hyde(1886), Arthur Machen's “Novel of the White Powder” (1895), and Rudyard Kipling's “Wireless” (1902). Bringing romance and drugs together invites readers to think about their respective claims to invigorate, transport, even remake the self.

HIV Cure Research: An example of successful advocacy by scientists for science

Following medical school and an internal medicine residency in Toronto, and infec-tious diseases training at the New England Medical Center/Tufts University in Boston, Jonathan joined the Division of Infectious Diseases, Department of Medicine at the Ottawa General Hospital in 1995. His research focuses on understanding how HIV damages the immune system and how these insights may lead to new therapies. Jon-athan is currently Professor of Medicine, University of Ottawa and Senior Scientist, Ottawa Hospital Research Institute. He was Editor-in-Chief of CIM from 2010–2015.

“I am a part of all that I have met”

Dr. Friesen received his MD from the University of Manitoba in 1958. He began his career in research in endocrinology with a fellowship at the New England Medical Center, Boston. His initial academic appointment was at McGill University (1965–1973), followed by appointment as Professor and Head of the Department of Phys-iology and Professor of Medicine at the University of Manitoba (1973–1992). His re-search resulted in the discovery of the human pituitary hormone prolactin, defining its role in health and disease.He served as the President of the Medical Research Council (1991–2000) where he was both architect and champion for a bold new vision for Health Research in Canada that led to the creation of the Canadian Institutes of Health Research in 2000. He was the founding Chair of Genome Canada (2000–2005), an agency established to position Canada to be a world leader in selected areas of genomics, and Chair of the Board of the Gairdner Foundation (2006–2009).

Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in Population Based Adults Free of Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis

1255 Joseph Yeboah, Gregory L Burke, John R Crouse, Wake Forest Univ Sch of Med, Winston Salem, NC; Joao A Lima, John Hopkins Univ, Baltimore, MD; Craig Johnson, Univ of Washington, Seattle, WA; Joseph F Polak, Tufts-New England Medical Ctr, Boston, MA; Aaron Folsom, Univ of Minnesota, Minneapolis, MN; Wendy Post, John Hopkins Univ, Baltimore, MD; David M Herrington, Wake Forest Univ Sch of Med, Winston Salem, NC Joseph Yeboah, 2008 Finalist and Presenting Author